Here are the 10-K annual reports from Arcadia Biosciences, Inc. (RKDA) in our archive since June 2025, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 10-K covers the audited annual report, with the full financial statements, so if you follow RKDA and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full RKDA filings page.
Arcadia Biosciences, Inc. filed an amendment to its 2025 annual report to add the required Part III information on directors, executive compensation, security ownership, related-party transactions, and auditor fees, without updating prior financial results.
The filing details the board and committee structure, independence determinations, and compensation for executives and non-employee directors, including option grants and severance and change in control agreements. It also describes expired equity plans and a January 2026 inducement transaction in which major holders exercised preferred investment options for cash proceeds of about $2.1 million and received new preferred investment options.
Arcadia Biosciences, Inc. reports 2025 product revenue of $4.9M, down slightly as GLA oil sales ended, while Zola coconut water revenue rose 17%. Net loss from continuing operations narrowed to $2.3M from $4.3M in 2024 as operating expenses declined.
The company recorded a $4.7M credit loss after Above Food defaulted on a promissory note from the 2024 GoodWheat sale, partially offset by a $2.0M gain from reducing contingent consideration and a $2.3M gain on AFII stock. Cash and cash equivalents were $0.3M at year-end, and auditors highlighted substantial doubt about Arcadia’s ability to continue as a going concern.
Arcadia has exited wheat trait commercialization and GoodWheat, now focusing on Zola coconut water sourced from Thailand amid evolving U.S. tariff policy. The Roosevelt Resources all-stock combination was terminated with no expected break-up fee, and the company faces a Proposition 65 lawsuit over BPA in canned coconut water and stockholder demand letters related to the terminated Roosevelt transaction.